Vasiliki Karlaftis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vasiliki Karlaftis has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Vera Ignjatovic
Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
16 shared publications - Paul Monagle
The University of Melbourne
15 shared publications - Chantal Attard
Haematology Research, Murdoch Children’s Research Institute, Melbourne, VIC, Australia
11 shared publications Paul Monagle
Murdoch Children’s Research Institute
6 shared publicationsChantal Attard
Murdoch Children’s Research Institute
4 shared publicationsJanet Burgess
Royal Children's Hospital Melbourne Australia
4 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in International Journal of Laboratory Hematology
The Impact of ABO and RhD Blood Groups on Laboratory Parameters in Children
Introduction: Developmental differences exist that impact laboratory reference intervals in children. Variances exist in ABO antigen expression and isohaemagglutinins through childhood. The impact of ABO and RhD blood group on laboratory parameters in children is unknown. Methods: The Harmonising Age Pathology Parameters in (HAPPI) Kids study is a prospective, cross‐sectional study, aiming to establish normative data for age‐appropriate reference intervals for laboratory parameters in healthy children. This study explores blood group‐related differences in laboratory parameters. Results: 2012 children had blood group testing. Haemoglobin was higher in group B compared with A (median difference 3.56 g/L [0.98–6.14]) ( p = 0.01) and red cell count (RCC) was higher in B compared with group A (0.23 × 10 12 /L [0.10–0.35]) ( p < 0.001) and O (0.19 × 10 12 /L [0.07–0.32]) ( p = 0.003). Haemoglobin and RCC were higher in B compared with non‐B. Group O had statistically lower Factor VIII levels than A (−0.40 IU/mL [−0.59 to −0.20]) ( p < 0.001), AB (−0.55 IU/mL [−0.73 to −0.36]) ( p < 0.001) and B (−0.45 [−0.81 to −0.10]) ( p = 0.027). VWF:Ag levels were lower in group O than A (−0.22 U/mL [−0.39 to −0.05]) ( p = 0.023) and B (−0.34 U/mL [−0.59 to −0.08]) ( p = 0.02). VWF:RCo was lower in group O than A (−0.34 U/mL [−0.50 to −0.17]) ( p < 0.001). Group O compared with non‐O had longer APTTs, lower FVIII and VWF parameters. No difference was found between RhD blood group and any parameter. Conclusion: This is the first study to explore whether ABO and RhD blood group impact routine laboratory parameters in children. Further studies are required to confirm the blood group‐related associations found and understand if ABO blood group impacts paediatric disease pathogenesis.
- 30 October 2026
- Published by Wiley in International Journal of Laboratory Hematology
The Impact of ABO and RhD Blood Groups on Laboratory Parameters in Children
Introduction: Developmental differences exist that impact laboratory reference intervals in children. Variances exist in ABO antigen expression and isohaemagglutinins through childhood. The impact of ABO and RhD blood group on laboratory parameters in children is unknown. Methods: The Harmonising Age Pathology Parameters in (HAPPI) Kids study is a prospective, cross‐sectional study, aiming to establish normative data for age‐appropriate reference intervals for laboratory parameters in healthy children. This study explores blood group‐related differences in laboratory parameters. Results: 2012 children had blood group testing. Haemoglobin was higher in group B compared with A (median difference 3.56 g/L [0.98–6.14]) ( p = 0.01) and red cell count (RCC) was higher in B compared with group A (0.23 × 10 12 /L [0.10–0.35]) ( p < 0.001) and O (0.19 × 10 12 /L [0.07–0.32]) ( p = 0.003). Haemoglobin and RCC were higher in B compared with non‐B. Group O had statistically lower Factor VIII levels than A (−0.40 IU/mL [−0.59 to −0.20]) ( p < 0.001), AB (−0.55 IU/mL [−0.73 to −0.36]) ( p < 0.001) and B (−0.45 [−0.81 to −0.10]) ( p = 0.027). VWF:Ag levels were lower in group O than A (−0.22 U/mL [−0.39 to −0.05]) ( p = 0.023) and B (−0.34 U/mL [−0.59 to −0.08]) ( p = 0.02). VWF:RCo was lower in group O than A (−0.34 U/mL [−0.50 to −0.17]) ( p < 0.001). Group O compared with non‐O had longer APTTs, lower FVIII and VWF parameters. No difference was found between RhD blood group and any parameter. Conclusion: This is the first study to explore whether ABO and RhD blood group impact routine laboratory parameters in children. Further studies are required to confirm the blood group‐related associations found and understand if ABO blood group impacts paediatric disease pathogenesis.
- 2 June 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (4) , 1-7
Reference intervals for haptoglobin in neonates and children 30 days to 18 years old
Haptoglobin is an acute phase plasma α2-glycoprotein produced by hepatocytes in the liver. Haptoglobin has a strong binding affinity (>1010 mol−1) for free hemoglobin (Hb), and irreversibly binds H...
- 2 June 2026
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (4) , 1-7
Reference intervals for haptoglobin in neonates and children 30 days to 18 years old
Haptoglobin is an acute phase plasma α2-glycoprotein produced by hepatocytes in the liver. Haptoglobin has a strong binding affinity (>1010 mol−1) for free hemoglobin (Hb), and irreversibly binds H...
- Open Access
Continuous reference intervals for total serum immunoglobulin E in neonates and children
- 1 October 2019
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 65 (10) , 1317-1326
Reference Values for 30 Common Biochemistry Analytes Across 5 Different Analyzers in Neonates and Children 30 Days to 18 Years of Age
BACKGROUND: Age-specific reference intervals (RIs) have been developed for biochemistry analytes in children. However, the ability to interpret results from multiple laboratories for 1 individual is limited. This study reports a head-to-head comparison of reference values and age-specific RIs for 30 biochemistry analytes for children across 5 analyzer types.METHODS: Blood was collected from healthy newborns and children 30 days to <18 years of age. Serum aliquots from the same individual were analyzed on 5 analyzer types. Differences in the mean reference values of the analytes by the analyzer types were investigated using mixed-effect regression analysis and by comparing maximum variation between analyzers with analyte-specific allowable total error reported in the Westgard QC database. Quantile regression was used to estimate age-specific RIs using power variables in age selected by fractional polynomial regression for the mean, with modification by sex when appropriate.RESULTS: The variations of age-specific mean reference values between analyzer types were within allowable total error (Westgard QC) for most analytes, and common age-specific reference limits were reported as functions of age and/or sex. Analyzer-specific reference limits for all analytes on 5 analyzer types are also reported as functions of age and/or sex.CONCLUSIONS: This study provides quantitative and qualitative measures of the extent to which results for individual children can or cannot be compared across analyzer types, and the feasibility of RI harmonization. The reported equations enable incorporation of age-specific RIs into laboratory information systems for improving evidence-based clinical decisions in children.
- 1 October 2019
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 65 (10) , 1317-1326
Reference Values for 30 Common Biochemistry Analytes Across 5 Different Analyzers in Neonates and Children 30 Days to 18 Years of Age
BACKGROUND: Age-specific reference intervals (RIs) have been developed for biochemistry analytes in children. However, the ability to interpret results from multiple laboratories for 1 individual is limited. This study reports a head-to-head comparison of reference values and age-specific RIs for 30 biochemistry analytes for children across 5 analyzer types.METHODS: Blood was collected from healthy newborns and children 30 days to <18 years of age. Serum aliquots from the same individual were analyzed on 5 analyzer types. Differences in the mean reference values of the analytes by the analyzer types were investigated using mixed-effect regression analysis and by comparing maximum variation between analyzers with analyte-specific allowable total error reported in the Westgard QC database. Quantile regression was used to estimate age-specific RIs using power variables in age selected by fractional polynomial regression for the mean, with modification by sex when appropriate.RESULTS: The variations of age-specific mean reference values between analyzer types were within allowable total error (Westgard QC) for most analytes, and common age-specific reference limits were reported as functions of age and/or sex. Analyzer-specific reference limits for all analytes on 5 analyzer types are also reported as functions of age and/or sex.CONCLUSIONS: This study provides quantitative and qualitative measures of the extent to which results for individual children can or cannot be compared across analyzer types, and the feasibility of RI harmonization. The reported equations enable incorporation of age-specific RIs into laboratory information systems for improving evidence-based clinical decisions in children.
- Open Access
A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
Introduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age, as well as sex and ethnicity. Differences in reagent formulations, methodologies and analysers can also impact on a reference interval. To date, no direct comparison of reference intervals for common analytes using different analysers in children has been published. The Harmonising Age Pathology Parameters in Kids (HAPPI Kids) study aims to establish age-appropriate reference intervals for commonly used analytes in the routine clinical care of neonates and children, and to determine the feasibility of paediatric reference interval harmonisation by comparing age-appropriate reference intervals in different analysers for multiple analytes. Methods and analysis The HAPPI Kids study is a prospective cross-sectional study, collecting paediatric blood samples for analysis of commonly requested biochemical, immunological and haematological tests. Venous blood samples are collected from healthy premature neonates (32–36 weeks of gestation), term neonates (from birth to a maximum of 72 hours postbirth) and children aged 30 days to ≤18 years (undergoing minor day surgical procedures). Blood samples are processed according to standard laboratory procedures and, if not processed immediately, stored at –80°C. A minimum of 20 samples is analysed for every analyte for neonates and then each year of age until 18 years. Analytical testing is performed according to the standard operating procedures used for clinical samples. Where possible, sample aliquots from the same patients are analysed for an analyte across multiple commercially available analysers. Ethics and dissemination The study protocol was approved by The Royal Children’s Hospital, Melbourne, Ethics in Human Research Committee (34183 A). The study findings will be published in peer-reviewed journals and shared with clinicians, laboratory scientists and laboratories.
Open AccessA prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
Introduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age, as well as sex and ethnicity. Differences in reagent formulations, methodologies and analysers can also impact on a reference interval. To date, no direct comparison of reference intervals for common analytes using different analysers in children has been published. The Harmonising Age Pathology Parameters in Kids (HAPPI Kids) study aims to establish age-appropriate reference intervals for commonly used analytes in the routine clinical care of neonates and children, and to determine the feasibility of paediatric reference interval harmonisation by comparing age-appropriate reference intervals in different analysers for multiple analytes. Methods and analysis The HAPPI Kids study is a prospective cross-sectional study, collecting paediatric blood samples for analysis of commonly requested biochemical, immunological and haematological tests. Venous blood samples are collected from healthy premature neonates (32–36 weeks of gestation), term neonates (from birth to a maximum of 72 hours postbirth) and children aged 30 days to ≤18 years (undergoing minor day surgical procedures). Blood samples are processed according to standard laboratory procedures and, if not processed immediately, stored at –80°C. A minimum of 20 samples is analysed for every analyte for neonates and then each year of age until 18 years. Analytical testing is performed according to the standard operating procedures used for clinical samples. Where possible, sample aliquots from the same patients are analysed for an analyte across multiple commercially available analysers. Ethics and dissemination The study protocol was approved by The Royal Children’s Hospital, Melbourne, Ethics in Human Research Committee (34183 A). The study findings will be published in peer-reviewed journals and shared with clinicians, laboratory scientists and laboratories.
- Open Access
- 1 May 2017
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 16 (5) , 924-935
Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults
- 1 May 2017
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 16 (5) , 924-935
Open AccessQuantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults
- 1 January 2016
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 27 (1) , 1-4
Importance of post-translational modifications on the function of key haemostatic proteins
Post-translational modifications (PTMs) such as glycosylation and phosphorylation play an important role on the function of haemostatic proteins and are critical in the setting of disease. Such secondary level changes to haemostatic proteins have wide ranging effects on their ability to interact with other proteins. This review aimed to summarize the knowledge of the common PTMs associated with haemostatic proteins and the implications of such modifications on protein function. Haemostatic proteins that represent the main focus for studies specific to PTMs are von Willebrand factor, tissue factor, factor VIII, antithrombin and fibrinogen. These proteins are susceptible to PTMs by glycosylation, phosphorylation, sulphation, citrullination and nitration, respectively, with a significant impact on their function. During synthesis, vWF must undergo extensive PTMs, with N-linked glycosylation being the most common. Increased phosphorylation of tissue factor results in increased affinity for platelets to the vessel endothelium. Citrullination of antithrombin leads to an increased anticoagulant function of this protein and therefore an anticoagulant state that inhibits clot formation. On the contrary, nitration of fibrinogen has been shown to result in a prothrombotic state, whilst sulphation is required for the normal function of Factor VIII. From this review, it is evident that PTMs of haemostatic proteins as a change in protein structure at a secondary level greatly influences the behaviour of the protein at a tertiary level.
- 1 January 2016
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 27 (1) , 1-4
Importance of post-translational modifications on the function of key haemostatic proteins
Post-translational modifications (PTMs) such as glycosylation and phosphorylation play an important role on the function of haemostatic proteins and are critical in the setting of disease. Such secondary level changes to haemostatic proteins have wide ranging effects on their ability to interact with other proteins. This review aimed to summarize the knowledge of the common PTMs associated with haemostatic proteins and the implications of such modifications on protein function. Haemostatic proteins that represent the main focus for studies specific to PTMs are von Willebrand factor, tissue factor, factor VIII, antithrombin and fibrinogen. These proteins are susceptible to PTMs by glycosylation, phosphorylation, sulphation, citrullination and nitration, respectively, with a significant impact on their function. During synthesis, vWF must undergo extensive PTMs, with N-linked glycosylation being the most common. Increased phosphorylation of tissue factor results in increased affinity for platelets to the vessel endothelium. Citrullination of antithrombin leads to an increased anticoagulant function of this protein and therefore an anticoagulant state that inhibits clot formation. On the contrary, nitration of fibrinogen has been shown to result in a prothrombotic state, whilst sulphation is required for the normal function of Factor VIII. From this review, it is evident that PTMs of haemostatic proteins as a change in protein structure at a secondary level greatly influences the behaviour of the protein at a tertiary level.
- 1 December 2015
- Published by Elsevier in Thrombosis Research
- Vol. 136 (6) , 1303-1309
Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults
- 1 December 2015
- Published by Elsevier in Thrombosis Research
- Vol. 136 (6) , 1303-1309
Differences in the mechanism of blood clot formation and nanostructure in infants and children compared with adults
- Retraction
- 1 November 2015
- Published by Elsevier in Thrombosis Research
- Vol. 136 (5) , 1045
Removal notice to “Characterisation of the Age-Specific Differences in Platelet Physiology and Function” [Thromb. Res. 133 (2014) S91]
- 1 November 2015
- Published by Elsevier in Thrombosis Research
- Vol. 136 (5) , 1045
RetractionRemoval notice to “Characterisation of the Age-Specific Differences in Platelet Physiology and Function” [Thromb. Res. 133 (2014) S91]